May 14, 2025 - 00:54
LANGHORNE, Pa., May 13, 2025 – Savara Inc., a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, has announced its financial results for the first quarter ending March 31, 2025. The company reported a net loss attributable to common stockholders of $12.5 million, compared to a loss of $10 million in the same period last year. This increase in loss is primarily due to heightened research and development expenses as Savara advances its pipeline of innovative therapies.
During the quarter, the company made significant progress in its clinical trials, particularly with its lead product candidate. The management expressed optimism regarding upcoming data readouts and emphasized their commitment to addressing unmet needs in the respiratory disease space.
Savara's strategic focus remains on leveraging its unique drug delivery technology to enhance patient outcomes. The company is actively exploring partnerships and collaborations to expand its reach and accelerate the development of its promising therapies.
October 20, 2025 - 01:32
The Importance of Communication Skills in Business by 2026A London-based training firm, which has successfully trained over 120,000 professionals globally, has emphasized the critical need for businesses to enhance their communication skills in the coming...
October 19, 2025 - 17:56
Spotlight on California's Energy Consultant ServicesIn a significant development for the energy sector, California`s Energy Consultant Services have been gaining recognition for their pivotal role in promoting sustainable practices and innovative...
October 19, 2025 - 01:46
New Leadership for Local Chamber of CommerceOct. 18—The Albert Lea-Freeborn County Chamber of Commerce has welcomed Valerie Lockhart as its new executive director, bringing nearly 20 years of experience in communications, digital marketing...
October 18, 2025 - 03:07
Airline Crew Provides Support to Air Traffic Controllers Amid ShutdownAirline pilots and flight attendants are stepping up to support air traffic controllers across the United States during the ongoing government shutdown. With air traffic controllers working without...